Home / Denmark / Zealand Pharma A/S
Zealand Pharma A/S
Short position disclosed on May 29, 2026.
6.75% of the capital sold short
8 disclosing funds
454 disclosures on record
DK0060257814 ISIN code
Evolution of the disclosed total
0%2%4%6%8%
Oct 2025Jan 2026Apr 2026Jul 2026
March 31, 2015 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Marshall Wace LLP | 1.29% | new | May 26, 2026 | |
| Voleon Capital Management LP | 1.11% | new | May 19, 2026 | |
| AHL Partners LLP | 0.91% | new | May 7, 2026 | |
| Citadel Advisors LLC | 0.83% | new | May 29, 2026 | |
| Connor Clark & Lunn Investment Management Ltd | 0.80% | new | April 28, 2026 | |
| Jupiter Asset Management Limited | 0.70% | new | March 12, 2026 | |
| Jennison Associates LLC | 0.61% | new | April 13, 2026 | |
| D. E. Shaw & Co., L.P. | 0.50% | new | May 11, 2026 |
On the other side: the funds that hold Zealand Pharma A/S Titelia
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| March 6, 2026 | Marshall Wace LLP | 1.37% | March 6, 2026 |
| March 6, 2026 | Voleon Capital Management LP | 0.63% | March 6, 2026 |
| March 6, 2026 | D. E. Shaw & Co., L.P. | 0.49% | March 6, 2026 |
| March 5, 2026 | AHL Partners LLP | 0.80% | March 5, 2026 |
| March 4, 2026 | Connor Clark & Lunn Investment Management Ltd | 0.60% | March 4, 2026 |
| March 3, 2026 | Marshall Wace LLP | 0.98% | March 3, 2026 |
| February 26, 2026 | AHL Partners LLP | 0.70% | February 26, 2026 |
| February 23, 2026 | Marshall Wace LLP | 1.00% | February 23, 2026 |
| February 23, 2026 | Connor Clark & Lunn Investment Management Ltd | 0.50% | February 23, 2026 |
| February 19, 2026 | Marshall Wace LLP | 0.97% | February 19, 2026 |
| February 18, 2026 | Connor Clark & Lunn Investment Management Ltd | 0.49% | February 18, 2026 |
| February 16, 2026 | Marshall Wace LLP | 0.81% | February 16, 2026 |
| February 13, 2026 | Voleon Capital Management LP | 0.51% | February 13, 2026 |
| February 11, 2026 | Marshall Wace LLP | 0.71% | February 11, 2026 |
| February 9, 2026 | Marshall Wace LLP | 0.63% | February 9, 2026 |
| February 5, 2026 | Connor Clark & Lunn Investment Management Ltd | 0.59% | February 5, 2026 |
| February 5, 2026 | Marshall Wace LLP | 0.53% | February 5, 2026 |
| February 2, 2026 | Connor Clark & Lunn Investment Management Ltd | 0.61% | February 2, 2026 |
| January 23, 2026 | D. E. Shaw & Co., L.P. | 0.59% | January 23, 2026 |
| January 20, 2026 | Connor Clark & Lunn Investment Management Ltd | 0.51% | January 20, 2026 |
| January 15, 2026 | AHL Partners LLP | 0.60% | January 15, 2026 |
| January 13, 2026 | Point72 Asset Management, LP | 0.48% | January 13, 2026 |
| January 6, 2026 | D. E. Shaw & Co., L.P. | 0.60% | January 6, 2026 |
| January 6, 2026 | Point72 Asset Management, LP | 0.58% | January 6, 2026 |
| January 5, 2026 | AHL Partners LLP | 0.50% | January 5, 2026 |
| December 15, 2025 | Point72 Asset Management, LP | 0.60% | December 15, 2025 |
| December 10, 2025 | D. E. Shaw & Co., L.P. | 0.59% | December 10, 2025 |
| December 8, 2025 | Point72 Asset Management, LP | 0.59% | December 8, 2025 |
| December 4, 2025 | Point72 Asset Management, LP | 0.61% | December 4, 2025 |
| December 3, 2025 | Point72 Asset Management, LP | 0.59% | December 3, 2025 |
| December 2, 2025 | Point72 Asset Management, LP | 0.60% | December 2, 2025 |
| November 14, 2025 | Citadel Advisors LLC | 0.49% | November 14, 2025 |
| November 13, 2025 | D. E. Shaw & Co., L.P. | 0.68% | November 13, 2025 |
| November 13, 2025 | Citadel Advisors LLC | 0.50% | November 13, 2025 |
| November 13, 2025 | Point72 Asset Management, LP | 0.09% | November 13, 2025 |
| November 6, 2025 | D. E. Shaw & Co., L.P. | 0.72% | November 6, 2025 |
| October 17, 2025 | Point72 Asset Management, LP | 0.50% | October 17, 2025 |
| October 10, 2025 | D. E. Shaw & Co., L.P. | 0.69% | October 10, 2025 |
| October 9, 2025 | D. E. Shaw & Co., L.P. | 0.70% | October 9, 2025 |
| September 26, 2025 | Arrowstreet Capital Limited Partnership | 0.49% | September 26, 2025 |
| September 23, 2025 | Arrowstreet Capital Limited Partnership | 0.58% | September 23, 2025 |
| September 22, 2025 | D. E. Shaw & Co., L.P. | 0.69% | September 22, 2025 |
| September 19, 2025 | AQR Capital Management, LLC | 0.49% | September 19, 2025 |
| September 18, 2025 | Arrowstreet Capital Limited Partnership | 0.69% | September 18, 2025 |
| September 16, 2025 | Arrowstreet Capital Limited Partnership | 0.78% | September 16, 2025 |
| September 10, 2025 | Canadian Pension Plan Investment Board | 0.49% | September 10, 2025 |
| September 8, 2025 | AQR Capital Management, LLC | 0.58% | September 8, 2025 |
| September 5, 2025 | D. E. Shaw & Co., L.P. | 0.79% | September 5, 2025 |
| September 4, 2025 | Arrowstreet Capital Limited Partnership | 0.87% | September 4, 2025 |
| September 3, 2025 | Canadian Pension Plan Investment Board | 0.59% | September 3, 2025 |
Other companies sold short in Denmark
- GN Store Nord A/S 4.81% of the capital sold short
- Ambu A/S 4.00% of the capital sold short
- Pandora A/S 2.25% of the capital sold short
- Carlsberg A/S 1.90% of the capital sold short
- Demant A/S 1.89% of the capital sold short
- Netcompany Group A/S 1.58% of the capital sold short
- Aquaporin A/S 1.51% of the capital sold short
- Matas A/S 1.28% of the capital sold short
- Noble Corporation Plc 1.17% of the capital sold short
- Novozymes A/S 1.00% of the capital sold short
- ChemoMetec A/S 0.92% of the capital sold short
- Coloplast A/S 0.79% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Zealand Pharma A/S, source Finanstilsynet, data as at May 29, 2026, https://www.quivad.com/action/zealand-pharma-a-s?page=2